Ravioli, Prediction Markets & Debates

This market resolves to Yes if Alibaba's XuanTie C950 CPU, developed on the RISC-V architecture, is commercially deployed in any AI application by December 31, 2026. Commercial deployment should be confirmed through official announcements by Alibaba or relevant industry reports.

This market resolves to Yes if Oscar Health's stock price is greater than $12 at market close on December 31, 2026. Oscar Health has been making significant strides in healthcare innovation despite financial losses, impacting its stock performance. This market evaluates the ability of Oscar Health to maintain its stock price amid ongoing challenges and opportunities in the healthcare sector.

Will the United Nations impose new sanctions on China due to its Uyghur policies by the end of 2026?

This market resolves to Yes if, by December 31, 2026, the United Nations implements new sanctions on China that are officially attributed to its treatment of Uyghurs. The determination will be based on credible reports from major international news organizations and official UN announcements.

This market resolves to Yes if IDEAYA Biosciences publicly releases the topline results of the Phase 2/3 OptimUM-02 trial for HLA-A2*-negative metastatic uveal melanoma by September 30, 2026. The announcement must be verifiable through a public or press release from IDEAYA Biosciences or a reputable news source. If no such announcement is made by the specified date, this market will resolve to No.

This market resolves to Yes if Universal Health Services successfully completes the acquisition of the virtual behavioral healthcare company Talkspace by October 1, 2026, as announced in the news. The resolution will be based on official announcements confirming the acquisition’s completion.

This market resolves to Yes if the Democratic Party wins a majority of seats in the Wisconsin State Senate as a result of the 2026 election. Official election results will confirm the resolution.

This market resolves to Yes if NICE (National Institute for Health and Care Excellence) approves funding for the new Alzheimer's treatment by November 30, 2026. The decision must be officially announced by NICE and reported in at least one major healthcare news outlet.